IBB

iShares Biotechnology ETF

ICE Biotechnology TR USD

NAV as of 02-Oct-2023

120.6403

4 Week: 119.32 - 127.68

52 Week: 117.58 - 138.43

Latest Closing Price

119.32

Premium / Discount

-0.02

Expense Ratio

0.45%

Investment Objective

The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Main Fund Characteristics

Fund Manager:
iShares
Asset Under Management:
6,976,799,623
Launch Date:
04/02/2001
Asset Class:
Equity
Replication Method:
Physical-Sample
Number of Holdings:
267
Trading Currency:
USD
Style:
Mid Blend
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-8.460.96-8.81
1 Day0.720.000.00
1 Week-2.381.82-1.30
1 Month-7.563.01-2.51
3 Months-5.236.06-0.86
6 Months-6.749.37-0.72
1 Year-2.0117.69-0.11
2 Years-22.8033.47-0.68
3 Years-10.2340.34-0.25
5 Years1.9556.870.03
10 Years-43.44135.06-0.32

Price History

-

Annual Performance Return

2013201420152016201720182019202020212022
Price (%) 65.471334.129311.4682-21.530321.2011-9.139324.746725.90130.9906-13.5920
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 4.000015.000021.000092.000063.000083.000049.000039.000073.000059.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
25/09/202301/10/20230.1532
06/06/202312/06/20230.0062
22/03/202328/03/20230.0646
12/12/202218/12/20220.1014
25/09/202229/09/20220.1586
08/06/202214/06/20220.0305
23/03/202229/03/20220.1176
12/12/202116/12/20210.0413
23/09/202129/09/20210.1244
09/06/202115/06/20210.0232

Portfolio Data

Total Number of Holdings: 267

Number of Bond Holdings: 0

Number of Equity Holdings: 261

Total Market Value: 6,976,799,623

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Gilead Sciences Inc7.433911,270,70687,050661,815,872

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant1.28
Large38.20
Medium40.00
Small12.22
Micro8.21

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

20.1256

Price/Book*

3.8766

Price/Sales*

4.7313

Price/Cash Flow*

17.2019

Dividend Yield*

0.6851

Growth Measures

Long-Term Earnings

6.8135

Historical Earnings

6.9309

Sales Growth

16.8051

Cash-Flow Growth

9.6955

Book-Value Growth

8.8004

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you